|
RG9MTD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.60870008822667E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.55530091214973E-11 |
| Normal-vs-Stage2 |
1.2699000000449E-06 |
| Normal-vs-Stage3 |
8.88520002018112E-09 |
| Normal-vs-Stage4 |
2.657200E-03 |
| Stage1-vs-Stage2 |
3.433800E-01 |
| Stage1-vs-Stage3 |
1.227590E-01 |
| Stage1-vs-Stage4 |
4.543600E-03 |
| Stage2-vs-Stage3 |
9.655200E-01 |
| Stage2-vs-Stage4 |
2.097200E-01 |
| Stage3-vs-Stage4 |
9.847800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60930055340225E-10 |
| Normal-vs-AfricanAmerican |
4.61963800546528E-13 |
| Normal-vs-Asian |
4.155700E-03 |
| Caucasian-vs-AfricanAmerican |
6.707000E-01 |
| Caucasian-vs-Asian |
2.844000E-01 |
| AfricanAmerican-vs-Asian |
4.474200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56540003182215E-10 |
| Normal-vs-Female |
2.7765000298885E-09 |
| Male-vs-Female |
2.704400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.34569999588052E-09 |
| Normal-vs-Extreme_Weight |
4.91969798233072E-11 |
| Normal-vs-Obese |
5.85550052889516E-10 |
| Normal-vs-Extreme_Obese |
6.27060000000235E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.757900E-02 |
| Normal_Weight-vs-Obese |
7.942400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.396200E-01 |
| Extreme_Weight-vs-Obese |
1.221820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.970600E-01 |
| Obese-vs-Extreme_Obese |
9.463800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.917400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.77640046905969E-10 |
| Normal-vs-Age(61-80Yrs) |
5.76769743076966E-11 |
| Normal-vs-Age(81-100Yrs) |
1.03119999994572E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.430200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.268250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.056200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.991900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.303800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.664400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6721002360498E-10 |
| Normal-VS-Type2 PRCC |
3.33489902359929E-11 |
| Normal-VS-KIRP CIMP |
2.060800E-01 |
| Normal-VS-Unclassified PRCC |
8.508604931734E-11 |
| Type1 PRCC-VS-Type2 PRCC |
3.245800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.838000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.723600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.844700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.667200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.438900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0463997163489E-10 |
| Normal-vs-N1 |
1.57897999999435E-05 |
| Normal-vs-N2 |
3.542000E-02 |
| N0-vs-N1 |
1.477990E-02 |
| N0-vs-N2 |
2.450800E-01 |
| N1-vs-N2 |
9.992000E-01 |
|
|
